Effect of long-term local or systemic hormone replacement therapy on post-menopausal mood disturbances. Influences of socio-economic and personality factors

Maturitas

Volumn 31, Issue 2, 1999, Pages 111-116

  Cagnacci, Angelo ^a   Neri, Isabella ^a   Tarabusi, Monica ^a   Volpe, Annibale ^a   Facchinetti, Fabio ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

Author keywords

Anxiety; Depression; Estrogens; Menopause; Mood; Psychological symptoms

Indexed keywords

AGENTS USED INTRAVAGINALLY; ESTRIOL; MEDROXYPROGESTERONE;

ADULT; AFFECTIVE NEUROSIS; ANXIETY; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; FEMALE; HORMONE SUBSTITUTION; HUMAN; INTRAVAGINAL DRUG ADMINISTRATION; MOOD; ORAL DRUG ADMINISTRATION; PERSONALITY; POSTMENOPAUSE; RATING SCALE; SOCIOECONOMICS; SOMATIZATION;

ADAPTATION, PSYCHOLOGICAL; ADMINISTRATION, INTRAVAGINAL; AFFECT; ANALYSIS OF VARIANCE; ESTRIOL; ESTROGEN REPLACEMENT THERAPY; FEMALE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; VAGINAL CREAMS, FOAMS, AND JELLIES;

EID: 0033049063     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(98)00094-2     Document Type: Article

References (32)

1. Bungay GT, Vessey MP, McPherson CK. Study of symptoms in middle life with special reference to the menopause. Br Med J 1980;ii:181-3.
2. Gath D, Iles S. Depression and the menopause. Br Med J 1990;300:1287-8.
3. Hunter MS. Somatic experience of the menopause: a prospective study. Psychosom Med 1990;52:357-67.
4. Hay AG, Bancroft J, Johnstone EC. Affective symptoms in women attending a menopause clinic. Br J Psych 1994;164:513-6.
5. Sherwin BB. Impact of the changing hormonal milieu on psychological functioning. In: Lobo RA (editor), Treatment of the Postmenopausal Woman: Basic and Clinical Aspects. New York:Raven Press, 1994;119-27.
6. Pearce J, Hawton K, Blake F. Psychological and sexual symptoms associated with the menopause and the effects of hormone replacement therapy. Br J Psych 1995;167:163-73.
7. Pearlstein TB. Hormones and depression: what are the facts about premenstrual syndrome, menopause, and hormone replacement therapy? Am J Obstet Gynecol 1995;173:646-53.
8. Panay N, Studd JWW. Menopause and the central nervous system. Eur J Menop 1996;3:242-9.
9. Ballinger CB. Psychiatric aspects of the menopause. Br J Psych 1990;156:773-87.
10. Kaufert PA, Gilbert P, Tate R. The Manitoba project: a re-examination of the link between menopause and depression. Maturitas 1992;14:143-55.
11. Neri I, Demyttenaere K, Facchinetti F. Coping style and climacteric symptoms in a clinical sample of postmenopausal women. J Psychom Obstet Gynecol 1997;18:229-33.
12. Klaiber EL, Broverman DM, Vogel W, Kobayashi Y. Oestrogen for severe persistent depression in women. Arch Gen Psychiatry 1979;36:550-4.
13. Holst J, Backstrom T, Hammarback S. Progestogen addition during oestrogen replacement therapy. Effects on vasomotor symptoms and mood. Maturitas 1989;11:13-20.
14. Montgomery JC, Appleby L, Brincat M. Effect of oestrogen and testosterone implants on psychological disorders in the climacteric. Lancet 1987;i:297-9.
15. Kimura D. Estrogen replacement therapy may protect against intellectual decline in postmenopausal women. Horm and Behav 1995;29:312-21.
16. Gerdes LC, Sonnendecker EWW, Polakow ES. Psychological changes effected by estrogen-progestogen and clonidine treatment in climacteric women. Am J Obstet Gynecol 1982;142:98-104.
17. Siddle NC, Fraser D, Whitehead MI, Jesinger DK, Endacott J, Prescott P, Pryse-Davies J. Endometrial, physical and psychological effects of postmenopausal oestrogen therapy with added dydrogesterone. Br J Obst Gynaecol 1990;97:1101-7.
18. Sherwin BB. The impact of different doses of estrogen and progestin on mood and sexual behavior in postmenopausal women. J Clin Endocrinol Metab 1991;72:336-43.
19. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol 1993;168:824-30.
20. Daly E, Gray A, Barlow D. Measuring the impact of menopausal symptoms on quality of life. Br Med J 1993;307:836-40.
21. Limouzin-Lamothe M, Mairon N, LeGal J. Quality of life after the menopause: influence of hormone replacement therapy. Am J Obstet Gynecol 1994;170:618-24.
22. Ditkoff EC, Crary WG, Cristo M, Lobo RA. Estrogen improves psychological function in asymptomatic postmenopausal women. Obstet Gynecol 1991;78:991-5.
23. Best N, Rees M, Barlow D, et al. Effect of estradiol implants on noradrenergic function and mood in menopausal patients. Psychoneuroendocrinology 1992;17:87-93.
24. Cagnacci A, Volpe A, Arangino S, et al. Depression and anxiety in climacteric women: role of hormone replacement therapy. Menopause 1997;4:206-11.
25. Zweifel JE, O'Brien WH. A meta-analysis of the effect of hormone replacement therapy upon depressed mood. Psychoneuroendocrinology 1997;22:189-212.
26. Kellner R, Sheffield BF. A self-rating scale of distress. Psychol Med 1973;3:88-100.
27. Schreurs PJG, Van de Willige C, Tellogen B, Brasschat JF. De utrechtse coping-list UCL. Tudschz Psychol 1984;12:101-17.
28. Cagnacci A, Melis GB, Soldani R, et al. Neuroendocrine and clinical effects of transdermal 17 β-estradiol in postmenopausal women. Maturitas 1991;13:283-96.
29. Kellner R, Sheffield BF. The use of self-rating test scales in a single-patient multiple cross-over trial. Br J Psych 1968;114:193-6.
30. Palinkas LA, Barrett-Connor E. Estrogen use and depressive symptoms in postmenopausal women. Obstet Gynecol 1992;80:30-6.
31. Melis GB, Cagnacci A, Bruni V, et al. Salmon calcitonin plus intravaginal estriol: an effective treatment for the menopause. Maturitas 1996;24:83-90.
32. Zichella L, Tesseri E, Falaschi P, et al. Psychoneuroendocrinology of postmenopausal hot flashes. In: Pancheri P, Zichella L (editors), Biorhythms and Stress in the Physiopathology of Reproduction. Hemisphere Publishing Corporation, New York, 1988; 549-65.